UB Paderborn / Katalog / Suche / in CDI

Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia

Brain (London, England : 1878), 2018-06, Vol.141 (6), p.1840-1854

2018

Link zum Volltext

Verfügbarkeit prüfen

First-in-human PET quantification study of cerebral α4β2 nicotinic acetylcholine receptors using the novel specific radioligand (−)-[18F]Flubatine

NeuroImage (Orlando, Fla.), 2015-09, Vol.118, p.199-208

2015

Link zum Volltext

Verfügbarkeit prüfen

Radiation dosimetry of the α4β2 nicotinic receptor ligand (+)-[18F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results

EJNMMI physics, 2016-10, Vol.3 (1), p.1-17, Article 25

2016

Link zum Volltext

Verfügbarkeit prüfen

The virtual reference radiologist: comprehensive AI assistance for clinical image reading and interpretation

European radiology, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

(+)[-[.sup.18]F]Flubatine as a novel [alpha]4[beta]2 nicotinic acetylcholine receptor PET ligand--results of the first-in-human brain imaging application in patients with [beta]-amyloid PET-confirmed Alzheimer's disease and healthy controls

European journal of nuclear medicine and molecular imaging, 2021-03, Vol.48 (3), p.731

2021

Link zum Volltext

Verfügbarkeit prüfen

Increased sigma-1 receptor (Sig-1R) binding in the brain of unmedicated patients with acute major depressive disorder (MDD) using the novel Sig-1R-specific radioligand (-)-[^sup 18^F]Fluspidine and PET

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.551

2018

Link zum Volltext

Verfügbarkeit prüfen

(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls

European journal of nuclear medicine and molecular imaging, 2021-03, Vol.48 (3), p.731-746

2021

Link zum Volltext

Verfügbarkeit prüfen

Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results

The Journal of nuclear medicine (1978), 2014-11, Vol.55 (11), p.1885-1892

2014

Link zum Volltext

Verfügbarkeit prüfen

Internal Dose Assessment of (-)-^sup 18^F-Flubatine, Comparing Animal Model Datasets of Mice and Piglets with First-in-Human Results

The Journal of nuclear medicine (1978), 2014-11, Vol.55 (11), p.1885

2014

Link zum Volltext

Verfügbarkeit prüfen

Internal Dose Assessment of (-)- super(18)F-Flubatine, Comparing Animal Model Datasets of Mice and Piglets with First-in-Human Results

The Journal of nuclear medicine (1978), 2014-11, Vol.55 (11), p.1885-1885

2014

Link zum Volltext

Verfügbarkeit prüfen

Internal Dose Assessment of (–)- 18 F-Flubatine, Comparing Animal Model Datasets of Mice and Piglets with First-in-Human Results

Journal of Nuclear Medicine, 2014-11, Vol.55 (11), p.1885-1892

2014

Link zum Volltext

Verfügbarkeit prüfen

First-in-human PET quantification study of cerebral alpha 4 beta 2 nicotinic acetylcholine receptors using the novel specific radioligand (-)-[18F]Flubatine

NeuroImage (Orlando, Fla.), 2015-09, Vol.118, p.199-208

2015

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of metabolism, plasma protein binding and other biological parameters after administration of (−)-[18 F]Flubatine in humans

Nuclear medicine and biology, 2014-07, Vol.41 (6), p.489-494

2014

Link zum Volltext

Verfügbarkeit prüfen

Fully automated radiosynthesis of both enantiomers of [18F]Flubatine under GMP conditions for human application

Applied radiation and isotopes, 2013-10, Vol.80, p.7-11

2013

Link zum Volltext

Verfügbarkeit prüfen

Management and therapy of vasovagal syncope: A review

World journal of cardiology, 2010-10, Vol.2 (10), p.308-315

2010

Link zum Volltext

Verfügbarkeit prüfen

Radiation dosimetry of the α 4 β 2 nicotinic receptor ligand (+)-[ 18 F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results

EJNMMI physics, 2016-12, Vol.3 (1), p.25

2016

Link zum Volltext

Verfügbarkeit prüfen

High-precision temperature profiling on paint lines

IST International Surface Technology, 2017-11, Vol.10 (3), p.62-63

2017

Link zum Volltext

Verfügbarkeit prüfen

Radiation dosimetry of the alpha sub(4) beta sub(2) nicotinic receptor ligand (+)-[ super(18)F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results

EJNMMI physics, 2016-12, Vol.3 (1), p.1-17

2016

Link zum Volltext

Verfügbarkeit prüfen

Radiation dosimetry of the [alpha]^sub 4^[beta]^sub 2^ nicotinic receptor ligand (+)-[^sup 18^F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results

EJNMMI physics, 2016-10, Vol.3 (1), p.1

2016

Link zum Volltext

Verfügbarkeit prüfen

First in man study to image alpha4beta2 cerebral nicotinic acetylcholine receptors (nAChRs) in early Alzheimer's disease (AD) with the new radioligand (-)-[18F]-norchloro-fluoro-homoepibatidine (NCFHEB) and PET

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.S37-S37

2011

Link zum Volltext

Verfügbarkeit prüfen

IC‐P‐069: First in man study to image alpha4beta2 cerebral nicotinic acetylcholine receptors (nAChRs) in early Alzheimer's disease (AD) with the new radioligand (‐)‐[18F]‐norchloro‐fluoro‐homoepibatidine (NCFHEB) and PET

Alzheimer's & dementia, 2011-07, Vol.7 (4S_Part_1), p.S37-S37

2011

Link zum Volltext

Verfügbarkeit prüfen

Neues Temperaturmesssystem für hohe Oberflächenqualität

JOT Journal für Oberflächentechnik, 2018-11, Vol.58 (S5), p.4-7

2018

Link zum Volltext

Verfügbarkeit prüfen

Neues Temperaturmesssystem für hohe Oberflächenqualität

JOT Journal für Oberflächentechnik, 2017-12, Vol.57 (12), p.52-55

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia

First-in-human PET quantification study of cerebral α4β2 nicotinic acetylcholine receptors using the novel specific radioligand (−)-[18F]Flubatine

Radiation dosimetry of the α4β2 nicotinic receptor ligand (+)-[18F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results

The virtual reference radiologist: comprehensive AI assistance for clinical image reading and interpretation

(+)[-[.sup.18]F]Flubatine as a novel [alpha]4[beta]2 nicotinic acetylcholine receptor PET ligand--results of the first-in-human brain imaging application in patients with [beta]-amyloid PET-confirmed Alzheimer's disease and healthy controls

Increased sigma-1 receptor (Sig-1R) binding in the brain of unmedicated patients with acute major depressive disorder (MDD) using the novel Sig-1R-specific radioligand (-)-[^sup 18^F]Fluspidine and PET

(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls

Associations between α4β2 nicotinic acetylcholine receptor (α4β2-nAChR) availability and memory, executive function and attention in mild Alzheimer’s dementia (AD): a (-)-[^sup 18^F]Flubatine PET investigation

Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results

Internal Dose Assessment of (-)-^sup 18^F-Flubatine, Comparing Animal Model Datasets of Mice and Piglets with First-in-Human Results

Internal Dose Assessment of (-)- super(18)F-Flubatine, Comparing Animal Model Datasets of Mice and Piglets with First-in-Human Results

Internal Dose Assessment of (–)- 18 F-Flubatine, Comparing Animal Model Datasets of Mice and Piglets with First-in-Human Results

First-in-human PET quantification study of cerebral [alpha]4[beta]2 nicotinic acetylcholine receptors using the novel specific radioligand (-)-[18F]Flubatine

First-in-human PET quantification study of cerebral alpha 4 beta 2 nicotinic acetylcholine receptors using the novel specific radioligand (-)-[18F]Flubatine

Evaluation of metabolism, plasma protein binding and other biological parameters after administration of (−)-[18 F]Flubatine in humans

Fully automated radiosynthesis of both enantiomers of [18F]Flubatine under GMP conditions for human application

Management and therapy of vasovagal syncope: A review

Radiation dosimetry of the α 4 β 2 nicotinic receptor ligand (+)-[ 18 F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results

High-precision temperature profiling on paint lines

Radiation dosimetry of the alpha sub(4) beta sub(2) nicotinic receptor ligand (+)-[ super(18)F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results

Radiation dosimetry of the [alpha]^sub 4^[beta]^sub 2^ nicotinic receptor ligand (+)-[^sup 18^F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results

First in man study to image alpha4beta2 cerebral nicotinic acetylcholine receptors (nAChRs) in early Alzheimer's disease (AD) with the new radioligand (-)-[18F]-norchloro-fluoro-homoepibatidine (NCFHEB) and PET

IC‐P‐069: First in man study to image alpha4beta2 cerebral nicotinic acetylcholine receptors (nAChRs) in early Alzheimer's disease (AD) with the new radioligand (‐)‐[18F]‐norchloro‐fluoro‐homoepibatidine (NCFHEB) and PET

Neues Temperaturmesssystem für hohe Oberflächenqualität

Neues Temperaturmesssystem für hohe Oberflächenqualität

Suchergebnisse filtern